KCM
WVE icon

Kennedy Capital Management’s Wave Life Sciences WVE Stock Holding History

Kennedy Capital Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.77M Buy
519,768
+27,331
+6% +$356K 0.08% 341
2025
Q4 		$8.37M Sell
492,437
-48,000
-9% -$488K 0.18% 195
2025
Q3 		$3.96M Buy
540,437
+506,437
+1,490% +$4.1M 0.09% 333
2025
Q2 		$221K Buy
+34,000
New +$225K 0.01% 562

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Kennedy Capital Management's WVE Position: Q1 2026 in Review

Kennedy Capital Management increased its Wave Life Sciences (WVE) stake by 5.6% in Q1 2026, buying an estimated $356K and bringing the position to 519,768 shares worth $3.77M. The position accounts for 0.08% of the portfolio, ranked #341.

Kennedy Capital Management first reported a position in WVE in Q2 2025 and has held it in 4 quarters since. The position peaked at $8.37M in Q4 2025. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • Kennedy Capital Management held 519,768 shares of Wave Life Sciences worth $3.77M as of Q1 2026.
  • Kennedy Capital Management bought 27,331 Wave Life Sciences shares in Q1 2026, an estimated $356K.
  • Wave Life Sciences made up 0.08% of Kennedy Capital Management's portfolio in Q1 2026, its #341 holding.
  • Kennedy Capital Management first reported a position in Wave Life Sciences in Q2 2025 and has held it in 4 quarters since.
  • Kennedy Capital Management's Wave Life Sciences position peaked at $8.37M in Q4 2025.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Kennedy Capital Management's 13F filing for Q1 2026, filed 13 May 2026.